Wolverine Trading, LLC Lineage Cell Therapeutics, Inc. Call Options Transaction History

Wolverine Trading, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 16, 2022	SELL	$1.21 - $2.48 $14,399 - $29,512	-11,900 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.84 - $2.68 $3,312 - $4,824	1,800 Added 17.82%	11,900 $30,000
Q3 2021 Nov 12, 2021	SELL	$2.26 - $2.86 $32,996 - $41,756	-14,600 Reduced 59.11%	10,100 $26,000
Q2 2021 Aug 06, 2021	BUY	$2.17 - $3.0 $10,416 - $14,400	4,800 Added 24.12%	24,700 $72,000
Q1 2021 May 14, 2021	SELL	$1.77 - $3.1 $37,347 - $65,410	-21,100 Reduced 51.46%	19,900 $45,000
Q4 2020 Feb 12, 2021	BUY	$0.95 - $1.83 $38,950 - $75,030	41,000 New	41,000 $71,000

121

94.2M

63.8K

Ticker LCTX
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 169,755,008
Market Cap $109M
Description
Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for the treatment of degenerative diseases in the United States and internationally. The company develops OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-re...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.